Neuro III Flashcards
succinylcholine
depolarizing agent
strong ACh agonist - resistance acetylcholinesterase
succinylcholine blockade phases
phase 1- prolonged depolarization - no antidote
phase 2 - repolarized but blocked - ACh receptor available but desensitized - antidote - cholinesterase inhibitor
adverse succinylcholine
hyperCa
hyperK
malignant hyperthermia
tubocurarine
nondepolarizing muscular blockage
atracurium
nondepolarizing muscular blockage
pancuronium
nondepolarizing muscular blockage
vecuronium
nondepolarizing muscular blockage
rocuronium
nondepolarizing muscular blockage
nondepolarizing muscular blockage
competitive antagonist - compete for ACh at receptors
reversal - neostigmine - with atropine - to prevent muscarinic effects - bradycardia
also - edrophonium and other cholinesterase inhibitor
dantrolene
prevent release Ca from SR of skeletal m
tx of malignant hyperthermia and neuroleptic malignant syndrome
baclofen
inhibit GABA-B - at spinal cord
skeletal m relaxation
cyclobenzaprine
central acting skeletal m relaxant
tx muscle spasms
bromocriptine
ergot dopamine agonist
pramipexole
non-ergot dopamine agonist
ropinirole
non-ergot dopamine agonist
amantadine
increase dopamine availability
increased DA release
decreased DA uptake
antiviral - influenza A and rubella
adverse amantadine
livedo reticularis
carbidopa
decreased peripheral conversion L-dopa
inhibit DOPA decarboxylase
entacapone
prevent peripheral L-dopa metabolism
inhibit COMT
tolcapone
prevent peripheral L-dopa metabolism
inhibit COMT
selegiline
block conversion DA > 3MT
-inhibit MAO-B
MAO-B in nerve terminal - metabolize dopamine over NE and 5-HT - so inhibit - more DA available
benztropine
anti-muscarinic
tx tremor and rigidity of parkinsons
little effect bradykinesia
tolcapone
inhibit COMT - peripheral AND centrally
memantine
NMDA receptor antagonist
tx of alzheimers
helps prevent excitotoxicity
donepezil
AChE inhibitor
tx of alzheimers
galantamine
AChE inhibitor
tx of alzheimers
rivastigmine
AChE inhibitor
tx of alzheimers
tacrine
AChE inhibitor
tx of alzheimers
huntington disease NT changes
decreased GABA
decreased ACh
increased DA
tetrabenazine
inhibit vesicular monoamine transport - limit dopamine vesicle pack and release
tx of huntington
reserpine
inhibit vesicular monoamine transport - limit dopamine vesicle pack and release
tx of huntington
haloperidol
D2 receptor antagonist
tx of huntington
triptans
5-HT 1B/1D agonist
inhibit trigeminal n activation
prevent vasoactive peptide release
induce vasoconstriction
tx migraine
sumatriptan
tx cluster HAs
sumatriptan
adverse triptans
coronary vasospasm
-CI prinzmetal angina